Novolog Pharm-Up 1966 Ltd (TA:NVLG) — Market Cap & Net Worth
Market Cap & Net Worth: Novolog Pharm-Up 1966 Ltd (NVLG)
Novolog Pharm-Up 1966 Ltd (TA:NVLG) has a market capitalization of $97.52 Million (ILA36.37 Billion) as of September 16, 2026. Listed on the TA stock exchange, this Israel-based company holds position #19387 globally and #249 in its home market, demonstrating a -6.32% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Novolog Pharm-Up 1966 Ltd's stock price ILA71.20 by its total outstanding shares 510874770 (510.87 Million). Also see total assets of Novolog Pharm-Up 1966 Ltd for a full breakdown of the balance sheet.
Novolog Pharm-Up 1966 Ltd Market Cap History: 2017 to 2026
Novolog Pharm-Up 1966 Ltd's market capitalization history from 2017 to 2026. Data shows change from $190.62 Million to $97.52 Million (-6.79% CAGR). Also see cash flow conversion of Novolog Pharm-Up 1966 Ltd for how efficiently the company converts equity into cash flow.
Novolog Pharm-Up 1966 Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Novolog Pharm-Up 1966 Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Novolog Pharm-Up 1966 Ltd (NVLG) share price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.10x
Novolog Pharm-Up 1966 Ltd's market cap is 0.10 times its annual revenue
Latest Price to Earnings (P/E) Ratio
41.80x
Novolog Pharm-Up 1966 Ltd's market cap is 41.80 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $190.62 Million | $839.84 Million | $22.49 Million | 0.23x | 8.47x |
| 2018 | $132.99 Million | $911.24 Million | $21.86 Million | 0.15x | 6.08x |
| 2019 | $207.93 Million | $1.00 Billion | $10.14 Million | 0.21x | 20.51x |
| 2020 | $381.43 Million | $1.13 Billion | $40.07 Million | 0.34x | 9.52x |
| 2021 | $377.05 Million | $1.26 Billion | $42.32 Million | 0.30x | 8.91x |
| 2022 | $359.67 Million | $1.51 Billion | $47.51 Million | 0.24x | 7.57x |
| 2023 | $187.53 Million | $1.64 Billion | -$42.00 Million | 0.11x | N/A |
| 2024 | $248.04 Million | $2.02 Billion | $39.54 Million | 0.12x | 6.27x |
| 2025 | $172.03 Million | $1.81 Billion | $4.12 Million | 0.10x | 41.80x |
Competitor Companies of NVLG by Market Capitalization
Companies near Novolog Pharm-Up 1966 Ltd in the global market cap rankings as of September 16, 2026. Review tangible net worth ratio of Novolog Pharm-Up 1966 Ltd to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Novolog Pharm-Up 1966 Ltd by market ranking:
- McKesson Corporation (NYSE:MCK): Ranked #250 globally with a market cap of $101.38 Billion USD.
- Cencora Inc. (NYSE:COR): Ranked #544 globally with a market cap of $50.53 Billion USD.
- Cardinal Health Inc (NYSE:CAH): Ranked #644 globally with a market cap of $43.01 Billion USD.
- Sigma Healthcare Ltd (AU:SIG): Ranked #1213 globally with a market cap of $21.48 Billion USD ( AU$30.36 Billion AUD).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #250 | McKesson Corporation | NYSE:MCK | $101.38 Billion | $910.95 |
| #544 | Cencora Inc. | NYSE:COR | $50.53 Billion | $326.23 |
| #644 | Cardinal Health Inc | NYSE:CAH | $43.01 Billion | $234.89 |
| #1213 | Sigma Healthcare Ltd | AU:SIG | $21.48 Billion | AU$2.63 |
Novolog Pharm-Up 1966 Ltd Historical Marketcap From 2017 to 2026
Between 2017 and today, Novolog Pharm-Up 1966 Ltd's market cap moved from $190.62 Million to $ 97.52 Million, with a yearly change of -6.79%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ILA97.52 Million | -43.31% |
| 2025 | ILA172.03 Million | -30.65% |
| 2024 | ILA248.04 Million | +32.27% |
| 2023 | ILA187.53 Million | -47.86% |
| 2022 | ILA359.67 Million | -4.61% |
| 2021 | ILA377.05 Million | -1.15% |
| 2020 | ILA381.43 Million | +83.44% |
| 2019 | ILA207.93 Million | +56.35% |
| 2018 | ILA132.99 Million | -30.23% |
| 2017 | ILA190.62 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 15th, 2026 the market cap of Novolog Pharm-Up 1966 Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $97.52 Million USD |
| MoneyControl | $97.52 Million USD |
| MarketWatch | $97.52 Million USD |
| marketcap.company | $97.52 Million USD |
| Reuters | $97.52 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Novolog Pharm-Up 1966 Ltd
Novolog (Pharm-Up 1966) Ltd provides healthcare services in Israel. The company operates through three divisions: Logistics, Healthcare Services, and Digital. The Logistics division engages in the import and distribution of pharmaceuticals and medical products; logistics of clinical trials and related services; provision of pharmaceutical services to customers; and sterilization and validation pr… Read more